Anyou Wang
Hefei, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Phase I/II Trial of the FLT3 Kinase Inhibitor XY0206 in Patients With Relapsed/Refractory Acute Myeloid Leukemia.
Journal: European journal of haematology
Published: October 10, 2025
Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in newly diagnosed and relapsed/refractory acute myeloid leukemia: results of a single center study.
Journal: Annals of hematology
Published: December 12, 2024
Clinical characteristics and analysis of related factors associated with early death in newly diagnosed patients with acute promyelocytic leukemia.
Journal: Discover oncology
Published: April 16, 2024
Palbociclib promotes the antitumor activity of Venetoclax plus Azacitidine against acute myeloid leukemia.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 27, 2022
Correlation Analysis and Prognostic Impacts of Biological Characteristics in Elderly Patients with Acute Myeloid Leukemia.
Journal: Clinical interventions in aging
Published: May 25, 2022
The expression of ADAMTS13 in human microvascular endothelial cells.
Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Published: September 15, 2015
All-trans retinoic acid modulates the balance of ADAMTS13 and VWF in human microvascular endothelial cells.
Journal: Microvascular research
Published: June 01, 2015
(Bortezomib plus lenalidomide/thalidomide)- vs. (bortezomib or lenalidomide/thalidomide)-containing regimens as induction therapy in newly diagnosed multiple myeloma: a meta-analysis of randomized controlled trials.
Journal: Annals of hematology
Published: April 13, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026